BMI View: Despite public sector financial challenges that continue to be posed by the expanding healthcare insurance coverage, we still envisage steady growth in medicine consumption and the use of medical services in Thailand. Commercial opportunities will increasingly be provided by the authorities’ desire to tackle the issue of the changing epidemiological profile of the country and also by growing incomes. However, downsides to our forecasts present themselves through the government’s open stance in relation to compulsory licencing, with the multinational pharmaceutical industry suggesting that such strategies are increasingly being used as a cost-cutting measure, rather than in real health …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=104109.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/thailand-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.
No comments:
Post a Comment